Keyphrases
Copy number Aberrations
100%
Chemo-naive
100%
Stage III Colorectal Cancer
100%
ERCC1
100%
ERCC4
33%
Colorectal Cancer
25%
Copy number Variation
16%
Colon Tumor
16%
Copy number Gain
16%
Aberrations
16%
Oxaliplatin Resistance
8%
Rectal Tumor
8%
Frequency Effect
8%
Fluorescence in Situ Hybridization
8%
Platinum Compounds
8%
Tumor Section
8%
Survival Statistics
8%
Colorectal Cancer Cell Lines
8%
Biomarker Profile
8%
Multivariate Analysis
8%
Local Recurrence
8%
Predictive Biomarker
8%
Platinum-based Chemotherapy
8%
HT-29
8%
Prognostic Impact
8%
Overall Survival Time
8%
Recurrence Rate
8%
Clinical Endpoints
8%
Patient Materials
8%
Hybridization Probes
8%
Reference Probe
8%
DNA Damage
8%
Patient Demographics
8%
Gene Copy number
8%
Long-term Survival
8%
Medicine and Dentistry
Colorectal Carcinoma
100%
Biological Marker
40%
Recurrent Disease
40%
Colon Tumor
40%
Multivariate Analysis
20%
DNA Damage
20%
Neoplasm
20%
Fluorescence in Situ Hybridization
20%
Oxaliplatin
20%
Cell Line
20%
Survival Time
20%
Overall Survival
20%
Metaphase
20%
Rectum Tumor
20%
Clinical Endpoint
20%
Cancer
20%
Gene Dosage
20%
Patient Population
20%
Platinum Derivative
20%
Colorectal Cancer Cell Line
20%
Rectum Cancer
20%
Immunology and Microbiology
Colon
100%
Overall Survival
50%
DNA Damage
50%
Cell Line
50%
Fluorescence in Situ Hybridization
50%
Metaphase
50%
Gene Dosage
50%
Colorectal Cancer Cell Line
50%
Survival Time
50%
Biochemistry, Genetics and Molecular Biology
ERCC1
100%
Colon
16%
Survival Time
8%
Cancer Cell
8%
Hybridization Probe
8%
DNA Damage
8%
Fluorescence in Situ Hybridization
8%
Gene Dosage
8%
Overall Survival
8%
Metaphase
8%
Multivariate Analysis
8%